Sign in
Taking people in United StatesNo phase

Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections

Key facts

Who runs it
Arkansas Children's Hospital Research Institute
Where
Atlanta, Austin, Boston, Chicago, Cincinnati, Cleveland, Columbus, Dallas, Durham, Houston, Indianapolis, Kansas City, La Jolla, Little Rock, Memphis, Milwaukee, Minneapolis, Nashville, New Haven, New York, Omaha, Orange, Palo Alto, Philadelphia, Portland, Saint Paul, San Francisco, Seattle, St Louis, St. Petersburg, and Washington D.C., United StatesSee the 32 sitesAlso in 1 other country, 1 site
Trial code
Status
Recruiting
People taking part
400 people, planned
Started
30 Oct 2018
Expected to end
31 Dec 2026
Type of study
Observational
Treatments tested
  • Non-Invasive Testing for PIFI
Record updated
25 September 2024

Who can take part

Age
120 days to 21 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Males or females age > 120 days and < 22 years at any participating site
  • Have at least one of the following conditions associated with a known high incidence of IFI: hematopoietic stem cell transplantation (HSCT), aplastic anemia, bone marrow failure, primary or acquired immune deficiency, or malignancy
  • New (last 96 hours) radiographic evidence of at least one of the following: at least one nodular lesion greater than or equal to 5 mm in size, a wedge-shaped and segmental or lobar consolidation, a cavitary lesion, a lesion with a halo sign, a lesion with a reverse halo sign, or a lesion with an air crescent sign
  • Prolonged neutropenia (absolute neutrophil count < 500 cells/µl for a period of ≥ 5 consecutive days) in 30 days prior to and including the day of qualifying chest MRI or CT scan date OR currently receiving systemic therapy for acute or chronic graft-versus-host disease (GVHD) OR presence of neutrophil dysfunction because of underlying acquired or primary immune deficiency (e.g. chronic granulomatous disease) on the date of the qualifying chest MRI or CT scan
  • Subject consent or parental/guardian permission (informed consent) and if appropriate, child assent

Who cannot take part

  • Previous inclusion in this study
  • Weight <3 kg, so as to not exceed 3 ml/kg in a single blood draw

This trial is currently available in United States.

Also in 1 other country, 1 site

  • Emory University & Children's Healthcare of Atlanta (CHOA)Atlanta, United StatesContact: PFN Central CoordinatorTaking people
  • Ascension Seton Medical CenterAustin, United StatesContact: PFN Central CoordinatorTaking people
  • Boston Children's HospitalBoston, United StatesContact: PFN Central CoordinatorTaking people
  • Ann & Robert H. Lurie Children's Hospital of ChicagoChicago, United StatesContact: PFN Central CoordinatorTaking people
  • University of Chicago Medicine- Comer Children'sChicago, United StatesContact: PFN Central CoordinatorTaking people
  • Cincinnati Children's Hospital Medical CenterCincinnati, United StatesContact: PFN Central CoordinatorTaking people
  • Cleveland ClinicCleveland, United StatesContact: PFN Central CoordinatorNo longer taking part
  • Nationwide Children's HospitalColumbus, United StatesContact: PFN Central CoordinatorTaking people
  • University of Texas Southwest Medical Center (UTSW)Dallas, United StatesContact: PFN Central CoordinatorTaking people
  • Duke University Medical CenterDurham, United StatesContact: PFN Central CoordinatorNo longer taking part
  • MD AndersonHouston, United StatesContact: PFN Central CoordinatorTaking people
  • Indiana University School of MedicineIndianapolis, United StatesContact: PFN Central CoordinatorTaking people
  • Children's MercyKansas City, United StatesContact: PFN Central CoordinatorTaking people
  • Rady Children's Hospital, UCSDLa Jolla, United StatesContact: PFN Central CoordinatorTaking people
  • Arkansas Children's Research InstituteLittle Rock, United StatesContact: PFN Central CoordinatorTaking people
  • St. Jude Children's Research HospitalMemphis, United StatesContact: PFN Central CoordinatorTaking people
  • Medical College of WisconsinMilwaukee, United StatesContact: PFN Central CoordinatorTaking people
  • University of Minnesota Medical SchoolMinneapolis, United StatesContact: PFN Central CoordinatorNo longer taking part
  • Monroe Carell Jr. Children's Hospital at VanderbiltNashville, United StatesContact: PFN Central CoordinatorTaking people
  • Yale UniversityNew Haven, United StatesContact: PFN Central CoordinatorTaking people
  • Weil Cornell Medical CollegeNew York, United StatesContact: PFN Central CoordinatorTaking people
  • Children's OmahaOmaha, United StatesContact: PFN Central CoordinatorTaking people
  • Children's Hospital of Orange CountyOrange, United StatesContact: PFN Central CoordinatorTaking people
  • Lucile Packard Children's Hospital Stanford UniversityPalo Alto, United StatesContact: PFN Central CoordinatorTaking people
  • The Children's Hospital Of PhiladelphiaPhiladelphia, United StatesContact: PFN Central CoordinatorTaking people
  • Oregon Health and Science UniversityPortland, United StatesContact: PFN Central CoordinatorTaking people
  • Children's MinnesotaSaint Paul, United StatesContact: PFN Central CoordinatorTaking people
  • University of California San Francisco-Benioff Children's HospitalSan Francisco, United StatesContact: PFN Central CoordinatorNo longer taking part
  • Seattle Children's Research InstituteSeattle, United StatesContact: PFN Central CoordinatorTaking people
  • The Washington UniversitySt Louis, United StatesContact: PFN Central CoordinatorTaking people
  • All Children's Research InstituteSt. Petersburg, United StatesContact: PFN Central CoordinatorNo longer taking part
  • Children's National HospitalWashington D.C., United StatesContact: PFN Central CoordinatorTaking people

About the trial

What the trial wants to find out

This study will establish a non-invasive diagnostic approach and evaluate clinical outcomes for children at high-risk for pulmonary invasive fungal infection (PIFI).

The group in the trial

  • Patients with possible PIFI

    Treatment: Non-Invasive Testing for PIFI

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
25 September 2024